Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Citi
AstraZeneca
Harvard Business School
Baxter
Medtronic
Chinese Patent Office
US Army
Federal Trade Commission

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020191

« Back to Dashboard

NDA 020191 describes ALOMIDE, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. Additional details are available on the ALOMIDE profile page.

The generic ingredient in ALOMIDE is lodoxamide tromethamine. One supplier is listed for this compound. Additional details are available on the lodoxamide tromethamine profile page.
Summary for 020191
Tradename:ALOMIDE
Applicant:Novartis Pharms Corp
Ingredient:lodoxamide tromethamine
Patents:0
Therapeutic Class:Ophthalmic Agents
Pharmacology for NDA: 020191
Physiological EffectDecreased Histamine Release
Suppliers and Packaging for NDA: 020191
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALOMIDE lodoxamide tromethamine SOLUTION/DROPS;OPHTHALMIC 020191 NDA Alcon Laboratories, Inc. 0065-0345 N 0065-0345-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrengthEQ 0.1% BASE
Approval Date:Sep 23, 1993TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Fuji
Healthtrust
Baxter
Argus Health
Accenture
Medtronic
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.